ClinicalTrials.gg
Not yet recruitingNCT07856901Updated Oct 5, 2026

Retinal and Choroidal Changes in Periodontal Disease

An observational study in Periodontal Diseases, Periodontal Diseases Inflammation and Retinal Thickening, sponsored by Zeliha Başak Çakır Erdil. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 20 Years to 54 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-05.

Sponsored by Zeliha Başak Çakır Erdil · Observational

How we know

Updated Oct 5, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
80
Ages
20 Years to 54 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 160 studies in Periodontal Diseases with a site in Turkey — 25 open to participants now, 34 under way, none of them phase 3. Periodontal Diseases · Turkey.

Planned enrollment
50th of 91
80 · median 88
Started
2026
with 21 others
Observational
91 of 160
14 open now
Primary completion
2026-10
later than 19 of 33 live
Registered
148th of 160
by date

Among the 160 studies in Periodontal Diseases with a site in Turkey, this one is the 50th largest by planned enrollment of the 91 observational ones that give a count, is one of 22 that started in 2026, is one of 91 observational ones, reaches primary completion later than 19 of the 33 other live ones, and was the 148th registered.

Periodontal Diseases

871 studies on the registry are indexed under Periodontal Diseases; 191 are open to participants now.

Browse Periodontal Diseases studies →

Open to participants now

25 of the 160 studies in Periodontal Diseases with a site in Turkey are open now. Recruiting first, the newest first:

19 more — sign in →

All 25 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 102 Periodontal Diseases studies recruiting now, 48 (47%) set no upper age limit and 42 (41%) stop at 75 or younger; 5 take children under 18; 59 take healthy volunteers.

This study: 20 Years to 54 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 160 studies in Periodontal Diseases with a site in Turkey, or all of them as a file.
02

Study summary

Advanced PeriodontitisIn this cross-sectional study, the relationship between periodontal disease severity and retinal and choroidal structural changes was evaluated using SD-OCT. Data from a total of 80 participants were examined. It was found that choroidal thickness increased and ganglion cell layer thickness decreased as periodontal disease severity increased, while no significant relationship was found in RNFL and IPL thicknesses. The findings support a possible association between periodontal disease and ocular structural changes.

Read the detailed description

Periodontal disease, by causing chronic inflammation, can affect not only oral tissues but also systemic organs. While the potential link between periodontal disease and eye diseases has attracted attention in recent years, data regarding retinal and choroidal structural changes are limited. In this study, periodontal clinical findings were compared with measurements of retinal nerve fiber layer (RNFL), ganglion cell layer (GCL), inner plexiform layer (IPL), and choroid thickness obtained using spectral-domain optical coherence tomography (SD-OCT) in a total of 80 individuals diagnosed with periodontal health, gingivitis, early periodontitis, and advanced periodontitis. The findings showed that choroidal thickness increased and GCL thickness decreased as the severity of periodontal disease increased. This study aims to contribute to a better understanding of the relationship between periodontal disease and ocular structural changes and to provide a basis for future prospective research.

Group 1: Periodontal Healthy

Participants with clinically healthy periodontal tissues and no evidence of gingivitis or periodontitis.

Group 2: Gingivitis

Participants diagnosed with gingivitis, presenting gingival inflammation without clinical attachment loss.

Group 3: Early Periodontitis

Participants diagnosed with early-stage periodontitis based on clinical periodontal examination.

Group 4: Advanced Periodontitis

Participants diagnosed with advanced periodontitis with greater periodontal tissue destruction.

03

Conditions studied

  • Periodontal Diseases
  • Periodontal Diseases Inflammation
  • Retinal Thickening

Keywords

  • Retinal degeneration ; Tomography, Optical Coherence ; Periodontitis ; gingivitis; Retinal Ganglion Cells ; Periodontal Index
04

Who can participate

Ages eligible
20 Years to 54 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population consisted of 80 systemically healthy, non-smoking adults who underwent comprehensive periodontal examination and spectral-domain optical coherence tomography (SD-OCT). Participants were classified into four groups according to their periodontal status (periodontally healthy, gingivitis, early periodontitis, and advanced periodontitis). All participants provided written informed consent before enrollment.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Systemically healthy adults. Non-smokers (no current or previous tobacco use). Participants who underwent optical coherence tomography (OCT) imaging. Participants who provided written and agreed to participate in the study.

Exclusion criteria

Exclusion Criteria:

Presence of any systemic disease. Current or former smokers. Participants with incomplete clinical or OCT data. Individuals who did not provide written .

-

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
80 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • Periodontal Healthy
  • Gingivitis
  • Early Periodontitis
  • Advanced Periodontitis
06

What researchers measure

Primary outcomes

  1. Correlation Between Periodontal Disease Severity and Choroidal Thickness

    The correlation between periodontal disease severity and choroidal thickness will be assessed using Spearman's correlation coefficient (rₛ). Periodontal disease severity will be assessed using probing pocket depth (PPD) and clinical attachment level (CAL), measured in millimeters (mm) using a periodontal probe. Choroidal thickness will be measured in micrometers (µm) using spectral-domain optical coherence tomography (SD-OCT).

    Time frame: Baseline

Secondary outcomes

  1. Correlation Between Periodontal Disease Severity and Retinal Nerve Fiber Layer (RNFL) Thickness

    The correlation between periodontal disease severity and retinal nerve fiber layer (RNFL) thickness will be evaluated. Periodontal disease severity will be assessed using clinical periodontal parameters, including probing pocket depth (PPD) and clinical attachment level (CAL), measured in millimeters (mm). RNFL thickness will be measured in micrometers (µm) using spectral-domain optical coherence tomography (SD-OCT). The correlation will be quantified using Spearman's correlation coefficient (rₛ).

    Time frame: Baseline

  2. Correlation Between Periodontal Disease Severity and Ganglion Cell Layer (GCL) Thickness

    The correlation between periodontal disease severity and ganglion cell layer (GCL) thickness will be evaluated. Periodontal disease severity will be assessed using clinical periodontal parameters, including probing pocket depth (PPD) and clinical attachment level (CAL), measured in millimeters (mm). GCL thickness will be measured in micrometers (µm) using spectral-domain optical coherence tomography (SD-OCT). The correlation will be quantified using Spearman's correlation coefficient (rₛ).

    Time frame: Baseline

  3. Correlation Between Periodontal Disease Severity and Inner Plexiform Layer (IPL) Thickness

    The correlation between periodontal disease severity and inner plexiform layer (IPL) thickness will be evaluated. Periodontal disease severity will be assessed using clinical periodontal parameters, including probing pocket depth (PPD) and clinical attachment level (CAL), measured in millimeters (mm). IPL thickness will be measured in micrometers (µm) using spectral-domain optical coherence tomography (SD-OCT). The correlation will be quantified using Spearman's correlation coefficient (rₛ).

    Time frame: Baseline

07

Study locations

1 site
  • Faculty of Dentistry, Adıyaman University
    Adıyaman, Adıyaman Province 02030, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared to protect participant confidentiality and privacy.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2026; primary completion for Oct 2026, 0 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 22, 2026
First posted
Oct 5, 2026
StartEst.
Oct 2026
Primary completionEst.
Oct 2026
CompletionEst.
Oct 2026
Last update
Oct 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 5, 2026
Show all 1 update
  1. Oct 5, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07856901
Lead sponsor
Zeliha Başak Çakır Erdil
Responsible party
Zeliha Başak Çakır Erdil (Research Assistant in Periodontology, Adiyaman University) — Sponsor-investigator
First posted
Oct 5, 2026
Start date
Oct 2026 (estimated)
Primary completion
Oct 2026 (estimated)
Completion
Oct 2026 (estimated)
Last update
Oct 5, 2026

Study contacts

Zeliha B ÇAKIR ERDİL, DDS
Contact
bskcakirr@gmail.com
+905059444038
Metin Çalışır, Prof.DR
Contact
metincalisir@adiyaman.edu.tr

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion